Similar articles

• Topical foscarnet for aciclovir-resistant mucocutaneous herpes infections in AIDS.

  Smith NA, Wood C, Asboe D, Bingham JS. Smith NA, et al. AIDS. 1997 Feb;11(2):254-5. AIDS. 1997. PMID: 9030377 No abstract available.
• [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].

  Morfin F, Frobert E, Thouvenot D. Morfin F, et al. Ann Biol Clin (Paris). 2003 Jan-Feb;61(1):33-40. Ann Biol Clin (Paris). 2003. PMID: 12604384 Review. French.
• [Antiviral resistance of herpes simplex virus and varicella-zoster virus].

  Daikoku T, Shiraki K. Daikoku T, et al. Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:480-6. Nihon Rinsho. 2007. PMID: 17455667 Review. Japanese. No abstract available.
• Oral therapy with acyclovir in infants and children.

  Arvin AM. Arvin AM. Pediatr Infect Dis J. 1987 Jan;6(1):56-8. doi: 10.1097/00006454-198701000-00014. Pediatr Infect Dis J. 1987. PMID: 3029659 Review. No abstract available.
• Antiviral drugs for varicella-zoster virus and herpes simplex virus infections.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2018 Sep 24;60(1556):153-157. Med Lett Drugs Ther. 2018. PMID: 30383727 Review. No abstract available.